FDA Recalls Unapproved Faiza Beauty Cream Distributed in New York
The FDA is recalling No. 1 Faiza Beauty Cream because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The source text does not report specific injuries or illnesses, aligning with a Moderate severity rating for unapproved drug marketing.
Plain-English summary
The U.S. Food and Drug Administration (FDA) is recalling No. 1 Faiza Beauty Cream. The product was manufactured by Poonia Brothers (Pak) in Gujranwala and distributed by Shata Traders Inc. in Brooklyn, New York. The recall involves 96 foil packages with Batch # 16L63 and Lot # 223190.
The recall was initiated because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). This classification indicates that the product is an unapproved new drug.
Consumers who have purchased this product should stop using it and contact the distributor, Shata Traders Inc., for further instructions.
The recalled product
- Product
- No. 1 Faiza Beauty Cream Manufactured by: Poonia Brothers (Pak), Gujranwala, Distributed by Shata Traders Inc., 4, 19th Street, Brooklyn, NY 11232. UPC 5842109854239
- Manufacturer
- Shata Trading, Inc.
- Hazard
- Affected units
- 96
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch # 16L63 Lot # 223190
Distribution
Distributed in 1 state:
Related recalls
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04